{
  "authors": [
    {
      "author": "Haiyong Wang"
    },
    {
      "author": "Hui Zhu"
    },
    {
      "author": "Li Kong"
    },
    {
      "author": "Jinming Yu"
    }
  ],
  "doi": "10.2147/OTT.S101241",
  "publication_date": "2016-08-25",
  "id": "EN114491",
  "url": "https://pubmed.ncbi.nlm.nih.gov/27555784",
  "source": "OncoTargets and therapy",
  "source_url": "",
  "licence": "CC BY-NC",
  "language": "en",
  "type": "pubmed",
  "description": "",
  "text": "In the first case, a patient presented with wild-type EGFR and negative ALK rearrangement. In the second case, a patient presented with wild-type EGFR and positive ALK rearrangement. In the third case, a patient presented with negative ALK rearrangement and mutated EGFR in exon 19."
}